| Alison Schaefer, MA CCC-SLP | |
|
231 Lucas Ln Apt 11, Voorhees, NJ 08043-2538 | |
| (856) 809-3500 | |
| Not Available |
| Full Name | Alison Schaefer |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 231 Lucas Ln Apt 11, Voorhees, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093117327 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 41YS00733700 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alison Schaefer, MA CCC-SLP 231 Lucas Ln Apt 11, Voorhees, NJ 08043-2538 Ph: () - | Alison Schaefer, MA CCC-SLP 231 Lucas Ln Apt 11, Voorhees, NJ 08043-2538 Ph: (856) 809-3500 |
News Archive
Adults treated with empagliflozin during hospitalization for acute heart failure experienced a clinical benefit such as increased survival, lower risk of heart failure hospital readmission and an overall improvement in their quality of life, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.
Optimer Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office has issued U.S. Patent 7,906,489 which covers methods of Clostridium difficile infection treatment with fidaxomicin.
Blocking certain enzymes in the cell may prevent cancer cell division and growth, according to new findings from researchers at the Graduate School of Biomedical Sciences at the Icahn School of Medicine at Mount Sinai.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
Most medications being tested today in clinical trials for the treatment of coronavirus disease 2019 (COVID-19) have been repurposed from other indications. These are typically not tested in pregnant women. A new study, published in the journal PLOS ONE, summarizes what is known about the safety of these drugs in this group.
› Verified 2 days ago
Mrs. Kristen Marie Devlin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 443 Laurel Oak Rd, Voorhees, NJ 08043 Phone: 856-309-8508 | |
Mrs. Stephanie Weiser, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 306 W Somerdale Rd, Voorhees, NJ 08043 Phone: 856-504-3150 Fax: 856-504-3157 | |
Stephanie Marie Callaghan, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2050 Voorhees Town Ctr, Voorhees, NJ 08043 Phone: 855-852-8150 | |
Amanda Williams, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Haddonfield Berlin Rd Ste 120, Voorhees, NJ 08043 Phone: 856-425-2239 | |
Mrs. Lauren S. Schwartzer, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 306 W Somerdale Rd, Voorhees, NJ 08043 Phone: 856-504-3150 Fax: 856-504-3157 | |
Ruth Blackman, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 50 Westminster Dr, Voorhees, NJ 08043 Phone: 856-296-0794 |